Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma (SABRseq)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03307759
Recruitment Status : Recruiting
First Posted : October 12, 2017
Last Update Posted : December 18, 2018
Sponsor:
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 4, 2021
Estimated Study Completion Date : November 4, 2021